48 related articles for article (PubMed ID: 23202783)
1. Clear cell carcinomas of the ovary: a multi-institutional study of 129 cases in Korea with prognostic significance of Emi1 and Galectin-3.
Min KW; Park MH; Hong SR; Lee H; Kwon SY; Hong SH; Joo HJ; Park IA; An HJ; Suh KS; Oh HK; Yoo CW; Kim MJ; Chang HK; Jun SY; Yoon HK; Chang ED; Kim DW; Kim I;
Int J Gynecol Pathol; 2013 Jan; 32(1):3-14. PubMed ID: 23202783
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance of c-Met and phospho-c-Met (Tyr1234/1235) in ovarian cancer.
Lim L; Wu CC; Hsu YT; Sun FJ; Chang CL
Taiwan J Obstet Gynecol; 2019 Jan; 58(1):105-110. PubMed ID: 30638462
[TBL] [Abstract][Full Text] [Related]
3. Endometriosis does not confer improved prognosis in ovarian clear cell carcinoma: a retrospective study at a single institute.
Zhao T; Shao Y; Liu Y; Wang X; Guan L; Lu Y
J Ovarian Res; 2018 Jun; 11(1):53. PubMed ID: 29941051
[TBL] [Abstract][Full Text] [Related]
4. Clear cell carcinoma of the ovary: Clinicopathologic features and outcomes in a Chinese cohort.
Tang H; Liu Y; Wang X; Guan L; Chen W; Jiang H; Lu Y
Medicine (Baltimore); 2018 May; 97(21):e10881. PubMed ID: 29794794
[TBL] [Abstract][Full Text] [Related]
5. Differences in Clinical and Biological Features Between Type I and Type II Tumors in FIGO Stages I-II Epithelial Ovarian Carcinoma.
Skirnisdottir I; Seidal T; Åkerud H
Int J Gynecol Cancer; 2015 Sep; 25(7):1239-47. PubMed ID: 26035126
[TBL] [Abstract][Full Text] [Related]
6. Preoperative discrimination of tumour stage in clear cell carcinoma of the ovary using computed tomography and magnetic resonance imaging.
Joo HL; Shin YR; Rha SE; Park CS; Shim DJ; Kim K
Eur J Radiol; 2018 Dec; 109():19-26. PubMed ID: 30527303
[TBL] [Abstract][Full Text] [Related]
7. Intratumoral budding is associated with poor clinical outcome in early-stage clear cell carcinoma of ovary.
Lin LH; Zamuco RD; Shukla PS
Histopathology; 2021 Dec; 79(6):1018-1029. PubMed ID: 34292622
[TBL] [Abstract][Full Text] [Related]
8. PIK3CA hotspot mutations and cyclooxygenase-2 expression in ovarian clear cell carcinomas: a close association with stromal features.
Kato N; Sato Y; Kamataki A; Fukase M; Uchigasaki S; Kurose A
Hum Pathol; 2019 Apr; 86():32-37. PubMed ID: 30496799
[TBL] [Abstract][Full Text] [Related]
9. [Ovarian clear cell borderline tumour: a clinicopathologic analysis].
Gu WY; Zhang LL; Zhang H; Pan QZ; Qu YQ; Tao X; Ning Y
Zhonghua Bing Li Xue Za Zhi; 2018 Aug; 47(8):622-626. PubMed ID: 30107668
[No Abstract] [Full Text] [Related]
10. Proposing a molecular classification associated with hypercoagulation in ovarian clear cell carcinoma.
Tamura R; Yoshihara K; Matsuo K; Yachida N; Miyoshi A; Takahashi K; Sugino K; Yamaguchi M; Mori Y; Suda K; Ishiguro T; Okuda S; Motoyama T; Nakaoka H; Kikuchi A; Ueda Y; Inoue I; Enomoto T
Gynecol Oncol; 2021 Nov; 163(2):327-333. PubMed ID: 34452748
[TBL] [Abstract][Full Text] [Related]
11. Clear cell carcinomas of the mullerian system: does the pathogenesis vary depending on their nuclear grade and their association with endometriosis? An immunohistochemical analysis.
Alduaij A; Hansen K; Karim TA; Zhang C; Lomme MM; Sung CJ; Lawrence WD; Quddus MR
Patholog Res Int; 2012; 2012():674748. PubMed ID: 23213623
[TBL] [Abstract][Full Text] [Related]
12. Clear Cell Carcinoma of the Endometrium: Evaluation of Prognostic Parameters in 27 Cases.
Zhang Z; Gao P; Bao Z; Zeng L; Yao J; Chai D; Li T
Front Oncol; 2021; 11():732782. PubMed ID: 34926250
[TBL] [Abstract][Full Text] [Related]
13. Transcriptome Analysis of Ovarian and Uterine Clear Cell Malignancies.
Alldredge J; Randall L; De Robles G; Agrawal A; Mercola D; Liu M; Randhawa P; Edwards R; McClelland M; Rahmatpanah F
Front Oncol; 2020; 10():598579. PubMed ID: 33415077
[TBL] [Abstract][Full Text] [Related]
14. p53, Mismatch Repair Protein, and POLE Abnormalities in Ovarian Clear Cell Carcinoma: An Outcome-based Clinicopathologic Analysis.
Parra-Herran C; Bassiouny D; Lerner-Ellis J; Olkhov-Mitsel E; Ismiil N; Hogen L; Vicus D; Nofech-Mozes S
Am J Surg Pathol; 2019 Dec; 43(12):1591-1599. PubMed ID: 31335355
[TBL] [Abstract][Full Text] [Related]
15. Morphologic and Immunohistochemical Study of Clear Cell Carcinoma of the Uterine Endometrium and Cervix in Comparison to Ovarian Clear Cell Carcinoma.
Ju B; Wang J; Yang B; Sun L; Guo Y; Hao Q; Wu J
Int J Gynecol Pathol; 2018 Jul; 37(4):388-396. PubMed ID: 28796747
[TBL] [Abstract][Full Text] [Related]
16. Case Series and a Literature Review: Two Ovarian Clear Cell Carcinoma Cases with Recurrent Endometriosis.
Yin D; Jiang YJ
Int J Womens Health; 2023; 15():1611-1619. PubMed ID: 37901720
[TBL] [Abstract][Full Text] [Related]
17. FBXO5 acts as a novel prognostic biomarker for patients with cervical cancer.
Jiang S; Zheng J; Cui Z; Li Y; Wu Q; Cai X; Zheng C; Sun Y
Front Cell Dev Biol; 2023; 11():1200197. PubMed ID: 37457292
[No Abstract] [Full Text] [Related]
18. Machine Learning Classification of Time since BNT162b2 COVID-19 Vaccination Based on Array-Measured Antibody Activity.
Ma QL; Huang FM; Guo W; Feng KY; Huang T; Cai YD
Life (Basel); 2023 May; 13(6):. PubMed ID: 37374086
[TBL] [Abstract][Full Text] [Related]
19. Identification of Human Cell Cycle Phase Markers Based on Single-Cell RNA-Seq Data by Using Machine Learning Methods.
Huang F; Chen L; Guo W; Huang T; Cai YD
Biomed Res Int; 2022; 2022():2516653. PubMed ID: 36004205
[TBL] [Abstract][Full Text] [Related]
20. The role of Fbxo5 in the development of human malignant tumors.
Gao J; Yang D; Cao R; Huang H; Ma J; Wang Z; Xia J; Pan X
Am J Cancer Res; 2022; 12(4):1456-1464. PubMed ID: 35530293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
